09.02.2014 Views

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

IV.<br />

DERIVATION OF CANCER POTENCY<br />

Basis for Cancer Potency<br />

Cancer potency factors for BCME were derived from male Sprague-Dawley rat respiratory tract tumor<br />

data (Kuschner et al., 1975; Leong et al., 1981). Cancer potency values are based on the most<br />

sensitive site, species and study demonstrating carcinogenicity of a particular chemical, unless other<br />

evidence indicates that the value derived from that data set is not appropriate (CDHS, 1985). The<br />

Kuschner et al. (1975) study used relatively high exposure levels of BCME. The exposure levels used<br />

in the Leong et al. (1981) study were lower, and the dose-response exhibited is highly non-linear.<br />

Therefore, a cancer potency estimated from the Leong et al. (1981) data set may be more<br />

representative of low-dose rate potency. For low dose exposures to BCME (below 1 ppb), the<br />

potency value was calculated from dose-response data published by Leong et al. (1981); for periodic<br />

high dose exposures (at or above 1 ppb BCME), the potency was derived from the study by Kuschner<br />

et al. (1975) (CDHS, 1988).<br />

Methodology<br />

Cancer potency factors (q 1<br />

*<br />

) were derived using a linearized multistage procedure (CDHS, 1985) with<br />

the dose-response data for male Sprague-Dawley rat respiratory tract tumors (Kuschner et al., 1975)<br />

and nasal tumors (Leong et al., 1981). Absorbed doses were calculated assuming complete absorption<br />

of inhaled BCME, using an inspiration rate of 0.29 m 3 /day for Sprague-Dawley rats. The dose from a<br />

continuous exposure to 1 ppb BCME (4.7 µg/m 3 ) would therefore be 1.36 µg/day, or 2.6 µg/kg-day.<br />

The cancer potency factors (q 1 * ) derived from the Leong et al. (1981) and Kuschner (1975) data sets<br />

were 8.9 (mg/kg/day) -1 and 47 (mg/kg/day) -1 , respectively. Surface area scaling was employed to<br />

transform animal cancer potency factors to human cancer potency factors, using the relationship (q human<br />

= q animal * (bw h / bw a ) 1/3 ), where q human is the human potency, q animal is the animal potency, and bw h and<br />

bw a are the human and animal body weights, respectively. Body weight values used for humans and<br />

Sprague-Dawley rats were 70 kg and 0.52 kg, respectively. The human cancer potency factors (q 1 * )<br />

derived from the Leong et al. (1981) and Kuschner (1975) data sets were 45.6 (mg/kg/day) -1 and 240<br />

(mg/kg/day) -1 , respectively. The unit risk factor was derived by <strong>OEHHA</strong>/ATES from the low dose<br />

exposure cancer potency value using a reference human body weight of 70 kg and an inspiration rate of<br />

20 m 3 /day.<br />

V. REFERENCES<br />

California Department of Health Services 1988. Risk Specific Intake Levels for the Proposition 65<br />

Carcinogen: Bis(chloromethyl)ether. Reproductive and Cancer Hazard Assessment Section, Berkeley,<br />

CA.<br />

California Department of Health Services (CDHS) 1985. Guidelines for Chemical Carcinogen Risk<br />

Assessment and Their Scientific Rationale. CDHS, Health and Welfare Agency, Sacramento, CA.<br />

137

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!